DOI: https://doi.org/10.14710/jbtr.v7i1.10051

Prevalence and Risk Factors of ESBL-producing Enterobacteriaceae in The Community

Faculty of Medicine, Universitas Jenderal Soedirman, Indonesia

Received: 1 Jan 2021; Revised: 8 Mar 2021; Accepted: 19 Mar 2021; Available online: 30 Apr 2021; Published: 30 Apr 2021.
Open Access Copyright (c) 2021 Journal of Biomedicine and Translational Research

Citation Format:
Abstract

Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalosporin generation III already confirmed in 86 countries. Incredibly high carrier prevalence rates were also widely developed in Thailand, Egypt, and China. The Faculty of Medicine's research team at Jenderal Soedirman University, Purwokerto,  discovered at the beginning of 2018 that Extended Spectrum β-Lactamase (ESBL) E. coli carriers throughout the 2015 class students were 26.8 percent.

Objective: This research investigated the Prevalence and associated factors of ESBL-producing Enterobacteriaceae (EPE) asymptomatic carriers in the community.

Methods: The participant fill a questionnaire, and samples were taken from rectal swabs using Amies transport medium (Labware Charuzu), and then models were analyze using HiCrome ™ ESBL Agar Base (Himedia, India). Analysis of its Prevalence and Resistance Predictors uses IBM SPSS Statistics Version 22.0 for Windows (Armonk, NY: IBM Corp).

Results: The Prevalence of EPE asymptomatic carriers in the community in Purwokerto was 66.7%. In the bivariate analysis, subjects who took antacids in the last eight weeks, history of hospitalization in the previous 12 months, the habit of consuming milk, yogurt, cheese, meat, seafood, and raw vegetables did not show any significant difference. Frequent chicken and freshwater fish consumption tended to be a risk factor for ESBL-producing Enterobacteriaceae with PR 1.462, 95% CI (1.115-1.918); PR 1.666, 95% CI  (0.936-2.966); however, in the multivariate logistic regression analysis, this was not significant.

Conclusion: The Prevalence of EPE asymptomatic carriers in the community in Purwokerto is 66.7%. All variables did not become any significant of ESBL-producing Enterobacteriaceae. However, ESBL remains an emerging antimicrobial resistance.

Note: This article has supplementary file(s).

Fulltext View|Download |  common.other
PREVALENCE AND RISK FACTORS ASYMPTOMATIC CARRIER EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE (EPE)
Subject
Type Other
  Download (21KB)    Indexing metadata
 common.other
PREVALENCE AND RISK FACTORS ASYMPTOMATIC CARRIER EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE (EPE)
Subject
Type Other
  Download (652KB)    Indexing metadata
Keywords: Carrier; Resistance; Risk Factors; Enterobacteriaceae; ESBL
Funding: LPPM, Jenderal Soedirman University

Article Metrics:

Article Info
Section: Original Research Articles
Language : EN
Recent articles
Prevalence and Risk Factors of ESBL-producing Enterobacteriaceae in The Community Effect of Aerobic Exercise on Left Ventricular Connexin43 Expression and Distribution in Juvenile and Young Adult Rats B- Acute Lymphoblastic Leukemia L2 In Second Trimester of Pregnancy Degree of coronary occlusions links to the patient clinical outcome: four cases of double culprits acute ST-segment elevation myocardial infarction Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond Prerequisite Evaluation of Anaerobic Settings for Gut Microbiome Functional Studies More recent articles
  1. Murray PR, Rosenthal, KS, Pfaller, MA. Basic Medical Microbiology. 8th ed. Philadelphia: Elsevier; 2018. 65–69 p
  2. Abdul Rahman EM, El-Sherif RH. High rates of intestinal colonization with extended-spectrum lactamase-producing Enterobacteriaceae among healthy individuals. J Investig Med. 2011;59(8):1284–6
  3. Aruhomukama D. Review of phenotypic assays for detection of extended-spectrum β-lactamases and carbapenemases: A microbiology laboratory bench guide. Afr Health Sci. 2020;20(3):1090–108
  4. Zeng X, Lin J. Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria. Front Microbiol. 2013;4(128):1–6
  5. N. W. Current epidemiology of OXA-carbapenemases in Klebsiella. Clin Microbiol Infect. 2012;18(76):1–5
  6. Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Shankar BA, Munusamy E, Anandan S, Veeraraghavan B. Draft genome sequence of blaTEM-1-mediated cephalosporin-resistant Salmonella enterica serovar Typhi from bloodstream infection. J Glob Antimicrob Resist. 2016;7(1):11–2
  7. Hijazi SM, Fawzi MA, Ali FM, Abd El Galil KH. Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors. Ann Clin Microbiol Antimicrob. 2016;15(3):1–9
  8. Sun Q, Tärnberg M, Zhao L, Stalsby Lundborg C, Song Y, Grape M, et al. Varying high levels of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in rural villages in Shandong, China: Implications for global health. PLoS One. 2014;9(11):1–9
  9. Strömdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of fecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011;30(10):1159–62
  10. Solé M, Pitart C, Oliveira I, Fàbrega A, Muñoz L, Campo I, et al. Extended-spectrum β-lactamase-producing Escherichia coli fecal carriage in Spanish travelers returning from tropical and subtropical countries. Clin Microbiol Infect. 2014;20(10): O636-9
  11. Pana ZD, Zaoutis T. Treatment of extended-spectrum β-lactamase-producing enterobacteriaceae (ESBLS) infections: What have we learned until now? [version 1; referees: 2 approved]. F1000Research. 2018;7((F1000 Faculty Rev):1347):1–9
  12. Detsis M, Karanika S, Mylonakis E. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization with Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis∗. Crit Care Med. 2017;45(4):705–14
  13. Desta K, Woldeamanuel Y, Azazh A, Mohammod H, Desalegn D, Shimelis D, et al. High gastrointestinal colonization rate with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients: Emergence of carbapenemase-producing K. Pneumoniae in Ethiopia. PLoS One. 2016;11(8):1–14
  14. Juneja D, Singh O, Nasa P, Javeri Y, Dang R. Bloodstream esbl infection in critical care unit: Incidence, risk factors, and its impact on outcome. Crit Care Med. 2010;23(2):192–5
  15. Walker KJ, Lee YR, Klar AR. Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems. Can J Infect Dis Med Microbiol. 2018;2018(Article ID 3747521):1–6
  16. Rodriguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of Infections Caused by Extended-Spectrum-Beta-. Clin Microbiol Rev. 2018;31(2):e00079-17
  17. Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae -A Case-Control Study in a Low Prevalence Country. PLoS One. 2013;51(11–12):802–9
  18. Bezabih YM, Sabiiti W, Alamneh E, Bezabih A, Peterson GM, Bezabhe WM, et al. The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. J Antimicrob Chemother. 2020;76(1):22–9
  19. Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal Colonization with Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors among Healthy Individuals: A Systematic Review and Metaanalysis. Clin Infect Dis. 2016;63(3):310–8
  20. Severin JA, Lestari ES, Kloezen W, Lemmens-den Toom N, Mertaniasih NM, Kuntaman K, et al. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002. Trop Med Int Heal. 2012;6:150–3
  21. Otter JA, Natale A, Batra R, Tosas Auguet O, Dyakova E, Goldenberg SD, et al. Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London. Clin Microbiol Infect. 2019;25(10):1259–65
  22. Shitrit P, Reisfeld S, Paitan Y, Gottesman BS, Katzir M, Paul M, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: Prevalence and risk factors. J Hosp Infect. 2013;85(3):230–2

Last update:

No citation recorded.

Last update:

No citation recorded.